The patients with mutations in either of the NF genes may develop a wide variety of central and peripheral nervous system tumors, such as low- and high-grade astrocytomas, meningiomas, or schwannomas of cranial nerves, the last two being more frequently associated with NF2 deficiency. Here, NF2 is linked to schwannoma.